UN&UP Receives Prestigious NIH Phase II SBIR Award from the NHLBI for its Novel Electrophysiology System

 

Arrhythmias are a major cause of US mortality with ventricular fibrillation, ventricular tachycardia, and atrial fibrillation resulting in 430,000 annual deaths. Although catheter ablation is a proven treatment option, control of ablation catheters can be complex, resulting in imprecise and unreliable heart-wall contact leading to an increased likelihood of injury and arrhythmia recurrence.

UNandUP (short for “Unmet Needs and Underserved Populations”) is developing an affordable magneto-robotic platform which uses low magnetic fields to overcome limitations related to electrophysiology catheter navigational accuracy, stability, and applied forces.

It was an honor to invent Stereotaxis' magnetic navigation system more than 20 years ago, and I am happy to see that Stereotaxis' new Genesis uses the smaller magnets I designed in 2006. That said, our UN&UP team feels we can push magnetic navigation further than previously achieved.

If successful, the system will be 50X smaller and 10X cheaper than Stereotaxis' system and will be compatible with existing digital EP suites.

W'e’re excited to announce UN&UP has received a NIH Phase II SBIR award from the NHLBI to explore a transformative electrophysiology robotic system. 

As always, our research partners include key opinion leaders from Washington University, University of Pittsburgh Medical Center, and NHMFL/MagCorp.

We would like to thank BioGenerator and Bio STL for supporting this effort.

 
Previous
Previous

UN&UP Selected to Present at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference

Next
Next

UNandUP Awarded Entry into NIH’s Prestigious I-Corps Program for its Interventional Pulmonology Robot